威領股份(002667.SZ):預計半年度淨利潤為0萬元–500萬元
格隆匯7月14日丨威領股份(002667.SZ)公佈2025年半年度業績預吿,1-6月公司實現歸屬於上市公司股東的淨利潤盈利0萬元–500萬元,同比扭虧為盈;扣除非經常性損益後的淨利潤虧損6,900萬元–5,200萬元,基本每股收益盈利0.0000元/股–0.0211元/股。
公司經營發展穩中向好,核心競爭力持續增強。2025年上半年,公司在鞏固鋰產業鏈業務的同時,新增多金屬礦採選業務,利用不同礦種價格週期的錯配效應,增強了公司跨週期經營能力,提升了公司盈利的穩定性與抗風險能力。報吿期內,公司通過持續優化資源配置、提升資產運營效率、降低管理成本等舉措,進一步增強了盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.